Symbol="HOOK"
AssetType="Common Stock"
Name="Hookipa Pharma Inc"
Description="HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company is headquartered in New York, New York."
CIK="1760542"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="430 EAST 29TH STREET, 14TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="67532000"
EBITDA="-72220000"
PERatio="None"
PEGRatio="None"
BookValue="1.526"
DividendPerShare="0"
DividendYield="0"
EPS="-0.86"
RevenuePerShareTTM="0.221"
ProfitMargin="0"
OperatingMarginTTM="-4.735"
ReturnOnAssetsTTM="-0.264"
ReturnOnEquityTTM="-0.576"
RevenueTTM="15980000"
GrossProfitTTM="-52966000"
DilutedEPSTTM="-0.86"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.198"
AnalystTargetPrice="4.47"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.101"
PriceToBookRatio="0.379"
EVToRevenue="1.908"
EVToEBITDA="0.732"
Beta="0.692"
num_52WeekHigh="2.05"
num_52WeekLow="0.68"
num_50DayMovingAverage="1.116"
num_200DayMovingAverage="1.016"
SharesOutstanding="75224000"
DividendDate="None"
ExDividendDate="None"
symbol="HOOK"
open="0.88"
high="0.90"
low="0.85"
price="0.87"
volume="359264.00"
latest_trading_day="2023-07-21"
previous_close="0.88"
change="-0.01"
change_percent="-1.1364%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="21"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="79"
Volume_recent_avg="961268"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.75"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="79"
Aroon_momentum_negative="21"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="666"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
